subscribeSubscribe
Hospira`s Generic Epoetin Alfa Receives Supplemental Approval in US

Hospira`s Generic Epoetin Alfa Receives Supplemental Approval in US
FDA
30 Jun 2020
Share Share
Amgen Inc. v. Hospira, Inc. (Fed. Cir. 2019)

Amgen Inc. v. Hospira, Inc. (Fed. Cir. 2019)
PATENTDOCS
19 Dec 2019
Share Share
Federal Circuit Affirms Amgen’s $70 Million Damages Award Against Pfizer Unit

Federal Circuit Affirms Amgen’s $70 Million Damages Award Against Pfizer Unit
BIGMOLECULEWATCH
17 Dec 2019
Share Share
The top 10 franchise drugs in biopharma history will earn $1.4T (trillion)

The top 10 franchise drugs in biopharma history will earn $1.4T (trillion)
John Carroll ENDPTS
16 Aug 2019
Share Share
FibroGen sinks as roxadustat safety results confuse investors

FibroGen sinks as roxadustat safety results confuse investors
Nick Paul Taylor FIERCE BIOTECH
11 May 2019
Share Share
AZ preps new roxadustat filings, though data foxes investors

AZ preps new roxadustat filings, though data foxes investors
Phil Taylor PMLIVE
11 May 2019
Share Share
Hospira`s Retacrit (Epoetin Alfa-Epbx) Receives Approval in US

Hospira`s Retacrit (Epoetin Alfa-Epbx) Receives Approval in US
FDA
23 Jan 2019
Share Share
Pfizer launches biosimilar version of Amgen`s Epogen

Pfizer launches biosimilar version of Amgen`s Epogen
Jacob Bell BIOPHARMA DIVE
15 Nov 2018
Share Share
Sandoz`s Binocrit (epoetin alfa) Receives Approval in Europe

Sandoz`s Binocrit (epoetin alfa) Receives Approval in Europe
EMA
05 Oct 2018
Share Share
Medice Arzneimittel Pütter`s Abseamed (epoetin alfa) Receives Approval in Europe

Medice Arzneimittel Pütter`s Abseamed (epoetin alfa) Receives Approval in Europe
EMA
04 Oct 2018
Share Share